Reported 2 days ago
Conestoga Capital Advisors decided to sell its shares in Simulations Plus, Inc. (NASDAQ:SLP) due to slowing revenue growth, funding pressures on biotech clients, and elevated valuations compared to peers. Despite the company's focus on AI-driven drug discovery software, increasing competition and recent performance challenges prompted the decision to divest, as the firm sees potential in other AI stocks with better upside potential and lower risk.
Source: YAHOO